Press Release

Oncology Molecular Diagnostics Market Size, Share and Worldwide Trend Analysis & Forecast 2019-2026

Oncology Molecular Diagnostics Market Is predicted to grow; Collaborations and Mergers by Leading Players Will Support Growth, says Fortune Business Insights

The increasing prevalence of various types of cancer around world is driving the global oncology molecular diagnostics market, says Fortune Business Insights in a report, titled “Oncology Molecular Diagnostics Market Size, Share and Global Trend By Product (Instruments, Reagents), By Cancer Type (Blood Cancer, Prostate Cancer, Colorectal Cancer, Skin Cancer, Cervical Cancer), By Technology (Polymerase Chain Reaction, Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification), By End User (Hospitals, Diagnostic Centers) and Geography Forecast till 2026.” The rising shift towards precision medicine is expected to enable the growth of the global oncology molecular diagnostics market.

Browse Complete Report:

https://www.fortunebusinessinsights.com/industry-reports/oncology-molecular-diagnostics-market-101145

Major Leading Players Mentioned:

 

  • Abbott
  • Becton
  • Dickinson and Company
  • Hoffmann-La Roche Ltd
  • Cepheid
  • Bayer AG
  • Agilent Technologies
  • Danaher
  • Hologic
  • Sysmex Corporation
  • Siemens Healthcare GmbH.

Increasing Demand for Automated and Advanced Diagnostic Will Propel Growth

The increasing prevalence of numerous cancer is likely to back the growth of the global automated and advanced diagnostic market revenue. The rising shift towards precision medicine and increasing demand for preventive care is expected to boost the global oncology molecular diagnostics market growth.

Further, increasing demand for automated and advanced diagnostic techniques for cancer is also expected to aid the global oncology molecular diagnostics market shares. According to the World Health Organization, the number of cancer cases in the world in 2018 is estimated to be 18.0 million, which is expected to further fuel the global oncology molecular diagnostics market.

Get Sample PDF:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/oncology-molecular-diagnostics-market-101145

Furthermore, favourable health reimbursement policies are likely to foster the growth of the global oncology molecular diagnostics market. Moreover, Acquisition and mergers by key companies is predicted to stimulate the global oncology molecular diagnostics market growth during the forecast period. For instance, cancer Genetics announced merger with NovellusDx as a result of which Cancer Genetics portfolio of oncology test and services will combine with next-generation sequencing and other technologies of NovellusDx.

Similarly, Biodesix, Inc., announced the acquisition of Integrated Diagnostics, Inc. which resulted in acquisition of the company oncology product namely XL2 test. Additionally, the launch of MammaTyper is also expected to propel growth of the global oncology molecular diagnostics market. For instance, BioNTech SE launched MammaTyper, a molecular diagnostic test for breast cancer which was developed in collaboration with Stratifyer. However, high costs associated with molecular diagnostics, budgetary limitations, and the requirement of the sophisticated facility are the major factors predicted to hinder the growth of the global oncology molecular diagnostics Industry.

Rapid Adoption of Advanced Diagnostics Techniques Will Boost Growth in North America

Geographically, the global oncology molecular diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America and the Middle and Africa. North America is expected to dominate the global oncology molecular diagnostics market during the forecast period owing to the rapid adoption of advanced diagnostics techniques and sedentary lifestyles.  According to the American Cancer Society (ACS), melanoma or skin cancer is the most common type of cancer occurring in the U.S. and is estimated that approximately 91,270.

Favourable health reimbursement policies will further augment growth in the region. In Asia Pacific, the oncology molecular diagnostics market is predicted to grow at a significant rate owing to the growing geriatric population and rising research on precision medicines. The high unmet cancer needs are also expected to enable growth in Asia Pacific.

Speak to Analyst:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/oncology-molecular-diagnostics-market-101145

View More Reports:

What’s driving the Gene Therapy Market Growth? Prominent Players: Pfizer, Novartis, Bayer, Sanofi, GSK, Amgen, Boehringer Ingelheim International GmbH, uniQure, bluebird bio, Celgene

Smart Insulin Pens Market Size, Share | Top 10 companies | Exclusive Research Report by Fortune Business Insights

Vascular Grafts Market 2019 Profit Overview, Size, Global Trends, Top Key Players and Industry Growth by Forecast to 2026

Tags

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close